We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image
  • Published In : Aug 2023
  • Code : CMI4203
  • Pages :230
  • Formats :
      Excel and PDF
  • Industry : Medical Devices

The global spot vision screener market is estimated to be valued at US$ 227.2 million in 2023 and is expected to exhibit a CAGR of 6.0% during the forecast period (2023-2030).

Analysts’ Views on the Global Spot Vision Screener Market:

Increased government initiatives, research and development, product launches, and digital healthcare system deployment are expected to propel the market growth over the forecast period. For instance, in August 2021, RightEye, LLC, a healthcare technology company, launched eye care's first automated sensorimotor exam for binocular vision testing. RightEye Sensorimotor is a simple, all-in-one examination method that optometrists and ophthalmologists can use on every patient to objectively identify and treat binocular vision problems and oculomotor dysfunction.

Figure 1. Global Spot Vision Screener Market Share (%), By Indication Type, 2023

SPOT VISION SCREENER MARKET

To learn more about this report, request a free sample copy

Global Spot Vision Screener Market- Drivers

Government’s focus on the advancement of spot vision screener technology

Government’s focus on the advancement of spot vision screener technology is expected to drive the market growth over the forecast period. For instance, on March 3, 2023, Texas Health and Human Services issued the guidelines for vision screening and included American Optometric Association (AOA) vision screening guidelines which focuses on children’s eye care and surgery.

Rising initiatives regarding vision care screening

Rising initiatives regarding vision care screening are expected to drive the market growth over the forecast period. For instance, in March 2021, American Academy of Ophthalmology announced an initiative to protect children from the vision-threatening consequences of high myopia (nearsightedness). The company will make a five-year commitment to help underwrite the program approaches that advance myopia management as standard of care. The Academy-guided endeavor seeks to raise awareness of the increasing number of children at risk of developing high myopia and the effectiveness of new interventions to slow this common eye condition, so the worst consequences may be avoided. High myopia raises the risk of vision-threatening eye conditions such as retinal detachment, glaucoma, early cataracts, and myopic maculopathy, a leading cause of blindness world-wide.

 Figure 2. Global Spot Vision Screener Market Share (%), By Region, 2023

SPOT VISION SCREENER MARKET

To learn more about this report, request a free sample copy

Global Spot Vision Screener Market- Regional Analysis

Among region, North America is estimated to hold a dominant position in the global spot vision screener market over the forecast period owing to the increasing adoption of vision screening for eye diseases in this region. For instance, according to Centers for Disease Control and Prevention (CDC) estimated data of 2021, less than 15% of all preschool children receive an eye exam and less than 22% of preschool children receive some type of vision screening in the U.S. According to the American Optometric Association, 80% of a child’s learning is visual, hence, the detection of vision problems is considered important.

Global Spot Vision Screener Market- Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe, and the World Health Organization (WHO) declared it a public health emergency on January 30, 2020.

COVID-19 affected the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries, such as China, India, Saudi Arabia, the U.A.E., Egypt, and others, faced problems regarding the transportation of drugs from one place to another.

However, the COVID-19 pandemic had a negative impact on the global spot vision screener market owing to decreased screening of spot vision due to the COVID-19 outbreak. For instance, in February 2022, according to a study published in the Ophthalmology and Therapy Journal, patient-initiated no-shows and active postponement by eye care institutions due to the COVID-19 outbreak contributed to the reduction in elective outpatient attendance and vision care screening.

Spot Vision Screener Market Report Coverage

Report Coverage Details
Base Year: 2022 Market Size in 2023: US$ 227.2 Mn
Historical Data for: 2018 to 2021 Forecast Period: 2023 to 2030
Forecast Period 2023 to 2030 CAGR: 6.0% 2030 Value Projection: US$ 342.1 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Indication Type: Myopia, Hyperopia, Astigmatism, Anisometropia, Strabismus, Anisocoria
  • By End User: Hospitals, Specialty Centers, Others
Companies covered:

Hillrom, Essilor, OCULUS, FIM Medical, Adaptica, Honeywell International Inc., Plusoptix Inc., Health Access, LLC, Stereo Optical Company Inc., Visionix, and AEYE Health

Growth Drivers:
  • Government’s focus on the advancement of spot vision screener technology 
  • Rising initiatives regarding vision care screening
Restraints & Challenges:
  • Poor accessibility to eye care services in middle income countries

Global Spot Vision Screener Market- Segmentation

The global spot vision screener market report is segmented into indication type, end user, and region.

Among indication type, the global spot vision screener market is segmented into myopia, hyperopia, astigmatism, anisometropia, strabismus, and anisocoria. Out of which, the myopia segment dominated the market over the forecast period, and this growth is attributed due the increasing prevalence of vision-associated problems.

Among end user, the global spot vision screener market is segmented into hospitals, specialty centers, and others. Out of which, the hospital segment is expected to showcase growth in the global spot vision screener market over the forecast period, and this is attributed to the increasing number of targeted patient pools, growing awareness about health concerns, and the increasing number of hospitals worldwide.

Among region, the global spot vision screener market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. Out of which, the North America segment is expected to show promising growth in the global spot vision screener market over the forecast period, and this is attributed to rising product launches as well as the increasing prevalence of vision-associated problems.

Among all segmentation, the myopia segment has the highest potential due to the increasing product launches by the key market players over the forecast period. For instance, in September 2022, Welch Allyn, a U.S-based manufacturer of medical devices and patient monitoring device company, announced the launch of systemsSpot Vision Screener VS100S-B, a portable, handheld device designed to help quickly and easily detect vision problems in patients from six months of age. The Vision Screener is an easy-to-use auto-refractor that identifies refractive errors and ocular misalignment in children and adults. The portable, handheld device tests for refractive errors quickly and efficiently from a non-invasive, 1-meter distance.

Global Spot Vision Screener Market- Cross Sectional Analysis

Among indication type, the myopia segment held a dominant position in North America owing to the rising burden of eye disorders and growing awareness among the population. For instance, in 2021, the Canadian Ophthalmological Society, during Glaucoma Awareness Month, stated that glaucoma affects more than 800,000 Canadians every year. Glaucoma could affect more people in Canada in the coming years, which is predicted to drive the market growth.

Global Spot Vision Screener Market- Key Developments

On February 13 2023, Gaize, Inc., an automated testing device for discovering and capturing evidence of impairment announced the launch of its real-time impairment screening device. The product is a first-of-its-kind fully automated, non-invasive and portable eye movement test. It combines well-established Drug Recognition Expert (DRE) eye examinations.

On March 13, 2023, Visionix, a global manufacturer of ophthalmic diagnostic devices, announced a new multimodal device update with its second-generation VX 650. VX 650 is an advanced anterior segment analyzer with retinal imaging. The enhanced wavefront-based aberrometer's "quick mode" and new capture flexibilities can decrease screening time by half, offering improved product efficiency.

In November 2022, AEYE Health, a digital health company that provides fully autonomous, Artificial Intelligence (AI)-based diagnostic screening solutions for retinal imaging received 510(k) clearance for a system that uses artificial intelligence to diagnose diabetic retinopathy from retinal images which can cause spot vision. The U.S Food and Drug Administration (FDA) clearance positions AEYE Health to sell a technology that achieved 93% sensitivity and 91.4% specificity in a clinical trial.

In September 2022, India Vision Institute (IVI), an India-based nongovernmental organization  working to provide access to underprivileged vision screening and a pair of free spectacles to those in need, has won the Vision2020 Dr. Jordan Kassalow Vision Spring Award.

Global Spot Vision Screener Market- Key Trends

Innovation in the vision screening

Innovation vision screening, which includes technological advancements in the screening of vision care is expected to fuel the growth of the market over the forecast period. For instance, in October 2022, Health Access LLC, a provider of qualitative and quantitative solutions and strategies to public health organizations worldwide, launched a vision screening app named 'The KidsVisionCheck app' to detect multiple eye diseases and disorders in children. The KidsVisionCheck vision screening app will be available for download to iOS and Android devices at no cost in January 2024.

Global Spot Vision Screener Market: Restraints

Poor accessibility to eye care services in middle income countries

Factors such as poor accessibility to eye care services in middle income countries, such as India, Ghana, and Bangladesh, are expected to hamper the market growth over the forecast period. For instance, on May 26, 2023, according to an article published in British Medical Journal, multiple strategies that consider the complexities of different settings are required to address eye care access. The World Health Organization’s (WHO) World Report on vision recommends that member states make eye care an integral part of Universal Health Coverage through ‘Integrated People-centered Eye Care (IPEC)’, where services are integrated across levels and services to support a broad spectrum of care for people across the life course. The IPEC strategy harmonizes international efforts to increase access to and the quality of eye care services with the WHO's framework for Integrated People-Centered Health Services and the building blocks of Middle Income Country health systems. So, to overcome the poor accessibility, the launch of various awareness campaigns regarding eye care services need to be employed in the middle income countries.

Global Spot Vision Screener Market- Key Players

The major players operating in the global spot vision screener market include Hillrom, Essilor, OCULUS, FIM Medical, Adaptica, Honeywell International Inc., Plusoptix Inc., Health Access, LLC, Stereo Optical Company Inc., Visionix, and AEYE Health.

Global Spot Vision Screener Market - Definition

A spot vision screener is a small, portable device designed to quickly and easily detect individuals with vision issues, from infants to adults. Spot screens both eyes simultaneously at a safe 3-foot distance. The touch-screen display enables one-touch activation, straightforward patient data management, and straightforward auto-refraction application setting.

Frequently Asked Questions

The market is estimated to be valued at US$ 227.2 million in 2023 and is expected to exhibit a CAGR of 6.0% between 2023 and 2030.

Government’s focus on the advancement of spot vision screener technology and rising initiatives regarding vision care screening are expected to drive the market growth.

Myopia is the leading indication type segment in the market.

Poor accessibility to eye care services in middle income countries is expected to hamper the market growth.

The major players operating in the market include Hillrom, Essilor, OCULUS, FIM Medical, Adaptica, Honeywell International Inc., Plusoptix Inc., Health Access, LLC, Stereo Optical Company Inc., Visionix, and AEYE Health.

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Request Discount
Logo

Reliability and Reputation

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Reliability and Reputation

27001:2022

Reliability and Reputation

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo